Article List

WPRIM Management System> DCMS> Chinese Journal of Cardiology> 2011> 39> 10

Volume: 39 Issue: 10

1. Potential link between follistatin-like protein and cardiovascular diseases.	Page:973—975
2. Update on apical hypertrophic cardiomyopathy.	Page:970—972
3. The current therapy of right ventricular dysfunction in pulmonary arterial hypertension.	Page:967—969
4. Association between marital status and prevalence of peripheral arterial disease among Beijing residents: a cross-sectional study.	Page:955—959
5. Association between overweight, obesity and arterial stiffness in community residents.	Page:950—954
6. Resveratrol improves coronary collateral circulation in pigs with experimental acute coronary occlusion.	Page:946—949
7. Association between systemic inflammation and autoimmunity parameters and plasma lipid in patients with rheumatoid arthritis.	Page:941—945
8. The efficacy and safety of tolvaptan on treating heart failure patients with hyponatremia.	Page:936—940
9. Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy.	Page:929—935
10. Aspirin response and related factors in aged patients.	Page:925—928
11. Left ventricular longitudinal rotation changes in patients with dilated cardiomyopathy detected by two-dimensional speckle tracking imaging.	Page:920—924
12. Value of cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis.	Page:915—919
13. Novel mutations of cardiac troponin T in Chinese patients with hypertrophic cardiomyopathy.	Page:909—914
14. Establishment of a cyanotic congenital heart defect porcine model with decreased pulmonary blood flow.	Page:905—908
15. Determination of pulmonary vascular resistance by improved right heart catheter in rat.	Page:901—904
16. Clinical characteristics and survival of patients with pulmonary veno-occlusive disease.	Page:896—900
17. Pay more attention to imaging assessments in patients with pulmonary hypertension.	Page:892—895
18. Update on the standardized management of acute pulmonary embolism.	Page:883—885
19. Follow application indication to avoid overuse of percutaneous coronary intervention procedure.	Page:883—883
20. Enhance specialist training and improve the capabilities of management on pulmonary vascular diseases in China.	Page:881—882